Inhibikase Therapeutics, Inc. Note Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Promissory Note by and between Inhibikase Therapeutics, Inc. and Flagship Consulting, Inc., dated October
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Convertible Revolving Demand Promissory Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting Inc., dated April 3, 2018
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Amended and Restated Second Convertible Revolving Demand Promissory 2020 Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 31, 2020
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Fifth Restatement and Amendment to Promissory Note, issued by Inhibikase Therapeutics, Inc. to McDaniel Law Firm, PC, dated June 30, 2020
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Second Convertible Revolving Demand Promissory 2019 Note, issued by Inhibikase Therapeutics, Inc. to Joseph Frattaroli, dated December 31, 2019
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Convertible Revolving Demand Promissory Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated April 3, 2018
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020